| 1 |
35523052 | Pharmacological Difference Between Platelet Aggregations in Cardioembolic Stroke Patients with Direct Oral Anticoagulants: A Pilot Study. | 2022 Jul |
1 |
| 2 |
32762584 | Factor Xa and thrombin induce endothelial progenitor cell activation. The effect of direct oral anticoagulants. | 2021 Aug 18 |
1 |
| 3 |
33709339 | Efficacy and Safety of Direct Oral Anticoagulants vs Warfarin in Patients with Chronic Kidney Disease and Dialysis Patients: A Systematic Review and Meta-Analysis. | 2021 Apr |
1 |
| 4 |
31520364 | Global thromboelastometry in patients receiving direct oral anticoagulants: the RO-DOA study. | 2020 Feb |
1 |
| 5 |
30591426 | Strategies of neutralization of the direct oral anticoagulants effect: review of the literature. | 2019 Feb 1 |
1 |
| 6 |
28412907 | Review of the Pharmacology of the Emerging Possibilities of the Direct Oral Anticoagulants' Reversal. | 2017 |
1 |
| 7 |
28439702 | A comparison of apixaban and dabigatran etexilate for thromboprophylaxis following hip and knee replacement surgery. | 2017 Jun |
1 |
| 8 |
26780749 | Stroke Prevention in Atrial Fibrillation: A Clinical Perspective on Trials of the Novel Oral Anticoagulants. | 2016 Apr |
1 |
| 9 |
26961375 | Dabigatran and rivaroxaban do not affect AA- and ADP-induced platelet aggregation in patients receiving concomitant platelet inhibitors. | 2016 Aug |
1 |
| 10 |
27354873 | Resolution of a warfarin and dabigatran-resistant left atrial appendage thrombus with apixaban. | 2016 Jun |
1 |
| 11 |
26060808 | Antithrombotic Management of Patients with Nonvalvular Atrial Fibrillation and Ischemic Stroke or Transient Ischemic Attack: Executive Summary of the Korean Clinical Practice Guidelines for Stroke. | 2015 May |
1 |
| 12 |
26731855 | [Novel oral anticoagulants--issues in clinical practice]. | 2015 Oct |
1 |
| 13 |
23460104 | [From heparin to apixaban: anticoagulants cut both ways?]. | 2014 Feb |
1 |
| 14 |
24381151 | Determination of direct oral anticoagulants from human serum samples. | 2014 Feb |
1 |
| 15 |
24497951 | Comparative evaluation of direct thrombin and factor Xa inhibitors with antiplatelet agents under flow and static conditions: an in vitro flow chamber model. | 2014 |
1 |
| 16 |
24893548 | Anticoagulation: where have we come from and where are we going? The evidence for and against novel anticoagulants. | 2014 Feb |
1 |
| 17 |
23463187 | Tissue factor-mediated activation of the prothrombin complex concentrate (PCC) is differently inhibited by dabigatran, rivaroxaban, and apixaban: potential clinical implication. | 2013 Nov-Dec |
1 |
| 18 |
23470494 | New oral anticoagulants in addition to single or dual antiplatelet therapy after an acute coronary syndrome: a systematic review and meta-analysis. | 2013 Jun |
1 |
| 19 |
23518332 | Intracerebral haemorrhage associated with antithrombotic treatment: translational insights from experimental studies. | 2013 Apr |
1 |
| 20 |
22370770 | Newer anticoagulants in cardiovascular disease: a systematic review of the literature. | 2012 Sep-Oct |
1 |
| 21 |
22592953 | [Anticoagulation. Modern concepts]. | 2012 Jun |
1 |
| 22 |
28496748 | Cost-Effective Medicines for Stroke Prophylaxis in Patients with Atrial Fibrillation. | 2012 Jun-Jul |
1 |
| 23 |
21044021 | Novel anticoagulants: new evidence for emerging drugs and their potential application in major lower limb surgery. | 2011 Jan |
1 |
| 24 |
28496710 | Prevention of Stroke in Patients With Atrial Fibrillation. | 2011 Dec |
1 |
| 25 |
20353992 | Antithrombotic treatment failures in antiphospholipid syndrome: the new anticoagulants? | 2010 Apr |
2 |
| 26 |
19071881 | Comparative pharmacodynamics and pharmacokinetics of oral direct thrombin and factor xa inhibitors in development. | 2009 |
1 |
| 27 |
16906775 | Oral anticoagulants in development: focus on thromboprophylaxis in patients undergoing orthopaedic surgery. | 2006 |
2 |